Feasibility and safety of biologic OviTex mesh in ventral mesh rectopexy: a prospective pilot study
M. A. Boom(Meander Medisch Centrum), Esther C. J. Consten(University Medical Center Groningen), Paul M. Verheijen(Meander Medisch Centrum), N. Wijffels(John Radcliffe Hospital), Emma M. van der Schans(University Medical Center Groningen)
Cited by 3
Related Papers
Endoscopic or surgical step-up approach for infected necrotising pancreatitis: a multicentre randomised trial
|The Lancet|2017|732
Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial
|The Lancet. Gastroenterology & hepatology|2019|326
Hartmann's procedure versus sigmoidectomy with primary anastomosis for perforated diverticulitis with purulent or faecal peritonitis (LADIES): a multicentre, parallel-group, randomised, open-label, superiority trial
|The Lancet. Gastroenterology & hepatology|2019|212
Long-term Outcome After Laparoscopic Ventral Mesh Rectopexy
|Annals of Surgery|2015|198